Structural analysis and antibody response to the extracellular glutathione S-transferases from Onchocerca volvulus

被引:21
作者
Sommer, A
Nimtz, M
Conradt, HS
Brattig, N
Boettcher, K
Fischer, P
Walter, RD
Liebau, E
机构
[1] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany
[2] LION Biosci AG, D-69120 Heidelberg, Germany
[3] Gesell Biotechnol Forsch mbH, D-38124 Braunschweig, Germany
关键词
D O I
10.1128/IAI.69.12.7718-7728.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Onchocerca volvulus is a human pathogenic filarial parasite which, like other parasitic nematodes, is capable of surviving in an immunologically competent host by employing a variety of immune evasion strategies and defense mechanisms including the detoxification and repair mechanisms of the glutathione S-transferases (GSTs). In this study we analyzed the glycosylation pattern and the immunological properties of extracellular O. volvulus GST1a and -1b (OvGST1a and -1b). The enzymes differ in only 10 amino acids, and both are glycoproteins that have cleavable signal peptides and unusual N-terminal extensions. These characteristics have not been described for other GSTs so far. Mass spectrometry analyses indicate that both enzymes carry high-mannose type oligosaccharides on at least four glycosylation sites. Glycosylation sites 1 to 3 of OvGST1a (OvGST1b sites 2 to 4) are occupied by truncated N-glycans (Man(2)GlcNAc2 to Man(5)GlcNAc(2)), and N glycosylation site 4 of OvGST1a (OvGST1b site 5) carries Man(5)GlcNAc2 to Man(9)GlcNAc(2). To analyze the capacity of these secretory GSTs to stimulate host immune responses, we studied the antibody responses of onchocerciasis patients against the native affinity-purified OvGST1a and -1b. By enzyme-linked immunosorbent assay we showed that OvGST1a and -1b are immunodominant antigens, with less than 7% nonresponder patients. A direct comparison of the antibody responses to the glycosylated and deglycosylated forms demonstrates the high immunogenicity of the N-glycans. Analyses of the antibody responses to the unusual N-terminal extension show an enhanced recognition of this portion by patients as opposed to recognition of the recombinant protein without extension.
引用
收藏
页码:7718 / 7728
页数:11
相关论文
共 57 条
[1]   Identification of chitinase as the immunodominant filarial antigen recognized by sera of vaccinated rodents [J].
Adam, R ;
Kaltmann, B ;
Rudin, W ;
Friedrich, T ;
Marti, T ;
Lucius, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) :1441-1447
[2]  
Albiez E J, 1988, Trop Med Parasitol, V39 Suppl 4, P331
[3]  
AURIAULT C, 1988, J IMMUNOL, V141, P1678
[4]   Reengineering the glutathione S-transferase scaffold:: A rational design strategy pays off [J].
Babbitt, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10298-10300
[5]   Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states [J].
Brattig, N ;
Nietz, C ;
Hounkpatin, S ;
Lucius, R ;
Seeber, F ;
Pichlmeier, U ;
Pogonka, T .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :838-842
[6]   STRONG IGG ISOTYPIC ANTIBODY-RESPONSE IN SOWDAH TYPE ONCHOCERCIASIS [J].
BRATTIG, NW ;
KRAWIETZ, I ;
ABAKAR, AZ ;
ERTTMANN, KD ;
KRUPPA, TF ;
MASSOUGBODJI, A .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (04) :955-961
[7]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[8]   PARASITIC HELMINTH GLUTATHIONE S-TRANSFERASES - AN UPDATE ON THEIR POTENTIAL AS TARGETS FOR IMMUNOTHERAPY AND CHEMOTHERAPY [J].
BROPHY, PM ;
PRITCHARD, DI .
EXPERIMENTAL PARASITOLOGY, 1994, 79 (01) :89-96
[9]   β-carbonyl substituted glutathione conjugates as inhibitors of O-volvulus GST2 [J].
Brophy, PM ;
Campbell, AM ;
van Eldik, AJ ;
Teesdale-Spittle, PH ;
Liebau, E ;
Wang, MF .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) :979-981
[10]  
Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36